Table 2 (Comparison of Progressors and Regressors in Calcium Scores)
From: Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management
PARAMETERS | Patients showing Progression of Calcium score | Patients showing Regression of Calcium score |
|---|---|---|
Age as a risk factor | 53/70 subjects (= 75.7%) | 19/23 subjects (= 82.6%) |
Positive Family History | 28/70 subjects (= 40%) | 10/23 subjects (= 43.5%) |
Hypertension | 37/70 subjects (= 52.9%) | 13/23 subjects (= 56.5%) |
Low HDL | 23/70 subjects (= 32.9%) | 9/23 subjects (= 39.1%) |
Smoking | 16/70 subjects (= 22.9%) | 2/23 subjects (= 8.7%) |
Diabetes mellitus | 17/70 subjects (= 24.3%) | 6/23 subjects (= 26.1%) |
Unhealthy Diet | 63/70 subjects (= 90%) | 19/23 subjects(= 82.6%) |
Lack of Exercise | 13/70 subjects (= 18.6%) | 8/23 subjects (= 34.8%) |
Mental Stress | 15/70 subjects (= 21.4%) | 5/23 subjects (= 21.7%) |
Lipid Lowering Treatment (Maximum Daily Dosage) | Atorvastatin 120 mg | Atorvastatin 180 mg |
| Â | Simvastatin 40 mg | Simvastatin 60 mg |
| Â | Lovastatin 120 mg | Lovastatin 80 mg |
| Â | Pravastatin 40 mg | Pravastatin 40 mg |
| Â | Fluvastatin 20 mg | Fluvastatin Absent |
| Â | Gemfibrozil 1,800 mg | Gemfibrozil 900 mg |
| Â | Fenofibrate 300 mg | Fenofibrate Absent |
| Â | Nicotinic Acid 200 mg | Nicotinic Acid Absent |
| Â | Benfluorex 450 mg | Benfluorex 900 mg |
| Â | Omega-3 Absent | Omega-3 tab 1 |
| Â | Sibutramine Absent | Sibutramine 10 mg |
| Â | Cholestyramine 4 grams | Cholestyramine 8 grams |
| Â | Ezetimibe 10 mg | Ezetimibe 10 mg |
Other Medications | AB (Alpha Blockers) | AB Absent |
| Â | ACEI (ACE Inhibitors) | ACEI (ACE Inhibitors) |
| Â | AMIO (Amiodarone) | AMIO Absent |
| Â | APR (Allopurinol) | APR (Allopurinol) |
| Â | ARB (Angiotensin Receptor Blocker) | ARB (Angiotensin Receptor Blocker) |
| Â | ASP (Aspirn) | ASP (Aspirn) |
| Â | AZL Absent | AZL (Alprazolam) |
| Â | BB (Beta Blockers) | BB (Beta Blockers) |
| Â | CCB (Ca. Channel Blockers) | CCB (Ca. Channel Blockers) |
| Â | CLP (Clopidogrel) | CLP (Clopidogrel) |
| Â | DIG (Digoxin) | DIG Absent |
| Â | DR (Diuretics) | DR (Diuretics) |
| Â | GTN Absent | GTN (Glyceryl Trinitrate) |
| Â | INS (Insulin) | INS Absent |
| Â | ISD (Isosorbide Dinitrate) | ISD Absent |
| Â | ISM (Isosorbide Mononitrate) | ISM (Isosorbide Mononitrate) |
| Â | OH (Oral Hypoglycaemics) | OH (Oral Hypoglycaemics) |
| Â | POE (Plant Oestrogens) | POE (Plant Oestrogens) |
| Â | PPF Absent | PPF (Propafenone) |
| Â | T3 (Triiodothyronine) | T3 Absent |
| Â | T4 (Thyroxine) | T4 (Thyroxine) |
| Â | TM (Trimetazidine) | TM (Trimetazidine) |
| Â | WAR (Warfarin) | WAR Absent |